genOway Société anonyme: Business Overview, Financials & Competitive Analysis
genOway specializes in providing genetically modified mouse and rat models for biopharmaceutical companies, laboratories and research institutes, offering services including site-specific transgenesis, gene deletion, ...
Cyborg Score thesis
Niche biotech with stable customer base and IP strength, but constrained growth trajectory and volatile stock...
Read the full analyst-debate transcript →Get the Latest genOway Société anonyme Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreegenOway Société anonyme Overview
Pro stress-test →genOway specializes in providing genetically modified mouse and rat models for biopharmaceutical companies, laboratories and research institutes, offering services including site-specific transgenesis, gene deletion, humanization, and gene knock-down. The company serves a critical niche in the research and drug development ecosystem.
Strategic Profile
Pro stress-test →genOway is a market leader building on a broad exclusive technology platform and strong intellectual property combining patents and licensing rights. It has secured commercial contracts with major pharmaceutical leaders (BMS, Janssen, Novartis, Pfizer) and prestigious academic research centers.
Competitive Landscape
Pro stress-test →genOway operates in a specialized preclinical research models market with limited direct competitors. Major pharmaceutical and biotech companies either develop models in-house or outsource to specialized providers like genOway. The competitive advantage lies in proprietary technology, IP portfolio, and established relationships with pharmaceutical leaders and academic institutions.
Industry Context
genOway Société anonyme operates in Biotechnology & Medical Research (Preclinical Research Models).
Key facts
Founded: 1999 · Headquarters: Lyon, France · Employees: 143-148 · Revenue: €27.53M · Market cap: €22.5M